going from mounjaro to retatrutide Move over, Ozempic and Mounjaro. A new weight loss peptide is on the horizon—and it may be even better. Meet retatrutide, and find out what we know about it so far. Click Retatrutide: The New Triple-Agonist Weight
Description
Kids will steal it
Does the GIP receptor agonism in retatrutide affect the heart
For weight management , NHS eligibility is more restrictive
Although there is no medically approved diet plan for GLP-1 medications, healthcare professionals suggest the following eating options
Treatment discontinuation due to adverse event occurred in 4% to 11% of retatrutide-treated participants compared with 5% on placebo
